Form 8-K - Current report:
SEC Accession No. 0001193125-26-216723
Filing Date
2026-05-11
Accepted
2026-05-11 16:05:14
Documents
11
Period of Report
2026-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sepn-20260511.htm   iXBRL 8-K 45891
2 EX-99.1 sepn-ex99_1.htm EX-99.1 110294
3 GRAPHIC img205902741_0.gif GRAPHIC 48011
  Complete submission text file 0001193125-26-216723.txt   342674

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sepn-20260511.xsd EX-101.SCH 25994
14 EXTRACTED XBRL INSTANCE DOCUMENT sepn-20260511_htm.xml XML 4933
Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42382 | Film No.: 26963115
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)